ABSTRACT
INTRODUCTION
Patients suffering from type 1 or type 2 diabetes mellitus are at 2-4 fold risk of cardiovascular events [1] . Vascular function was shown to be impaired at an early stage of the disease, before the onset of microalbuminuria. As a first step, in response to various noxious stimuli, loss [2] . Retinopathy, which is the leading cause of blindness in younger patients, nephropathy, which is the leading cause of end-stage renal disease in the Western world, and diabetic neuropathy are the most important clinical manifestations of the microvascular damage [3] . Endothelial dysfunction in diabetic patients can contribute to further increase of arterial stiffness, resulting in macrovascular complications as well. It has been demonstrated previously, that in patients with 5-10 year long history of diabetes despite preserved renal function subtle increase in blood pressure and largeartery stiffness can be observed. Similarly, type 1 diabetes is associated with accelerated stiffening of the elastic arteries. As a result, in terms of cardiovascular (CV) risk, the presence of diabetes is equivalent to 15 years of chronological age in non-diabetics [4] .
Recent reports have demonstrated that endothelial dysfunction is an independent predictor of future cardiovascular events in patients with atherosclerotic risk factors, in patients with stable ischemic heart disease, and in patients with acute coronary syndromes [5] . Therefore, the assessment of endothelial integrity and endothelial function has become of critical importance for the understanding of vascular pathophysiology and its clinical implications [6] . when it reflects from moving blood cells [7] . Postocclusive reactive hyperemia (PORH) test is used to estimate microvascular reactivity [8] . Local thermal hyperemia leads to a temperature-dependent increase in the cutaneous flow and achieves a maximal vasodilation between 42-44ºC.
This maximal vasodilation corresponds to the maximal vasodilator capacity of the vessels [7] . Endothelial function can be detected also by measuring the plasma levels of endothelium-derived regulatory proteins, such as soluble endothelial-leukocyte adhesion molecule 1 (sE-selectin), soluble intercellular adhesion molecule 1 (sICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and von Willebrand factor (vWF) [2] . Concerning the macrovascular system, augmentation index (AIX) and pulse wave velocity (PWV) are parameters of arterial stiffness of the peripheral resistance vessels and the aorta, respectively. These parameters were shown to be strong indicators of cardiovascular risk [9] .
Due to high cardiovascular risk in diabetic patients, the screening of micro-and macrovascular function holds importance, already in the early phase of the disease.
Therefore, in the current study, we aimed to broadly examine the vascular system from the microvasculature to the aorta, using non-invasive methods in patients suffer- 
MATERIAlS AND METhODS

Patients
Subjects with type 1 diabetes mellitus were recruited from the diabetes outpatient clinic of our hospital. We enrolled 36 patients with diabetes (DM I., 4 male, 32 female), age ranged from 22-47 years. Patients with hypertension were excluded from the study. We divided the DM I. group into two subgroups, based on the presence of the microvascular complications of diabetes. Retinopathy was examined by ophthalmologic evaluation, diag- Table 1 . 
RESUlTS
Patient characteristics
Patients' demographic data are shown in Table 1 . Mean age, systolic and diastolic blood pressure and BMI were comparable in all groups. Heart rate and blood glucose level were significantly higher in both diabetic groups compared to the control. Regarding the DMW and DMC groups, there were no significant differences in fructoseamine, HbA1c, glucose levels and insulin consumption.
Diabetes duration was significantly longer in patients with diabetic complications than in the DMW group.
microvascular-anD enDothelial Dysfunction
The change of flow during the PORH test was the highest in the control group (C) and the lowest in diabetic patients with complications (DMC) ( Figure 1A) . Figure 1D ). Figure 2B ).
hyPerkinesis in the systemic anD microvascular circulation
Although the patients did not receive any medications influencing heart frequency, heart rate was significantly Figure 3B ).
correlations
After adjustment to age, BMI, systolic and diastolic blood pressure, heart rate, gender and smoking, the differences in change of flow during PORH test, pulse wave velocity (PWV) and sE-selectin remained significant in a general regression model.
In diabetic patients, diabetes duration correlated significantly with AIX and PWV (AIX: r = 0.6, PWV: r = 0.43, p<0.05, respectively) ( Figure 4A, 4B ). Significant inverse 
DISCUSSION
Despite the fact that aggressive treatment of conventional cardiovascular (CV) risk factors may lead to marked reduction of CV mortality in diabetic patients, the absolute risk of cardiovascular disease (CVD) remains higher in patients with diabetes compared to those without DM [1] .
Diabetic autonomic neuropathy (as a result of microangiopathy), a serious and common complication of diabetes can lead to silent myocardial ischemia, which may impair the recognition of myocardial infarction and may delay revascularization therapy [14] . In type 1 diabetes mellitus vascular changes of large and small arteries occur at an early stage of the disease, even before the manifestation of clinical complications of diabetes [15, 16] . These findings suggest that appropriate screening of both micro-and macrovascular complications are very important, mainly in the young population. In our study we examined different parts of the vascular system (capillaries, small and large arteries) and endothelial function with non-invasive reproducible [7, 10, 11, 12] methods, which can also be used in clinical practice.
Postocclusive reactive hyperemia (PORH) and local heating test in type 1 diabetes mellitus
The laser-Doppler method is widely used to assess microvascular function in the skin. Postocclusive reactive hyperemia (PORH) represents a complex microvascular response to an acute period of ischaemia, while maximal thermal vasodilation corresponds to the vasodilator capacity of the vessels [7] . In concordance with our findings, previous studies demonstrated endothelial and microvascular dysfunction in early, uncomplicated type 1 diabetes mellitus [11, 17, 18] as well. Skrha and colleagues reported similar results in case of peak flow of PORH, and maximal flow of thermal hyperemia in type 1 diabetic patients with and without microvascular complications [19] . Tur and colleagues found that in patients with type 1 diabetes peak blood flow during PORH test was significantly lower compared to control subjects, and the ratio of peak flow and time to peak was lower in patients with retinopathy than in patients without microvascular complications [20] . 
Endothelial soluble markers in type 1 diabetes mellitus
The microvascular endothelium, with its very large surface area and synthetic capacity, is the most important determinant of plasma levels of endothelium-derived mediators [2] , therefore sE-selectin can be considered as a marker of microvascular endothelial dysfunction. In our study we found elevated levels of sE-selectin in diabetic patients. In consistence with our results, soluble sE-selectin levels were also found to be higher in diabetic patients in other studies [19, 21] . Results of laser-Doppler flowmetry and significantly higher sE-selectin levels altogether refer to a functional disturbance of the microvascular system of the patients with type 1 diabetes mellitus detected even in early stage.
Arterial stiffness in type 1 diabetes mellitus
Arterial stiffness is a powerful, independent predictor of cardiovascular disease [22] . Pulse wave velocity (PWV) of the aorta is considered to be a direct marker of arterial stiffness, referring the stiffness of large arteries. PWV is a strong predictor of mortality in diabetes mellitus, too.
Augmentation index is an indirect marker of arterial stiffness, represents mainly the peripheral resistance vessels, and is closely correlated with the cardiovascular risk [12] .
Systolic blood pressure, pulse pressure, age, heart rate and different medications (i.e. angiotensin-converting enzyme inhibitors, statins) can affect the measured values of arterial stiffness [12, 22] .
Unexpectedly, in our study, the DMW group had significantly better parameters of arterial stiffness (augmentation index and pulse wave velocity) than patients with complicated type 1 diabetes mellitus. However, there are some other studies available in the literature with corresponding conclusions. Vervoort and colleagues examined the forearm blood flow (FBF) in type 1 diabetic patients, and found that the basal FBF was elevated in diabetic patients compared to controls. The vascular response to norepinephrine was increased in the diabetic group, caused by lower baseline arterial plasma norepinephrine concentrations [23] . On contrary, several other studies found elevated large and small artery stiffness [15, 24] and diffuse arterial wall stiffening and thickening [16] in type 1 diabetic patients, even in the absence of any diabetic vascular complications.
We assume that our results can be explained by the insulin effect, or represent the manifestation of the early vasodilative phase of diabetes mellitus. Westerbacka et al.
examined the effect of physiological doses of insulin on large artery function by applanation tonometry and pulse wave analysis. They found that insulin caused a significant decrease in both central augmentation and peripheral augmentation index, which means an acute reduction in arterial stiffness [25] . Insulin has also been found to have a long-term beneficial effect on the progression of carotid intima-media thickness, another indicator of atherosclerosis [26] . According to Schalkwijk and colleagues, in reasonably well-controlled type 1 diabetes mellitus, endothelium-dependent and -independent vasodilation of resistance and conduit arteries are neither impaired nor enhanced. In addition, early, uncomplicated type 1 diabetes is accompanied rather by dilation, than constriction of small and large blood vessels [2] . This statement raises the possibility that better results of arterial stiffness measurements in early, uncomplicated type 1 diabetes mellitus do not necessarily refer to better clinical status regarding complications. Therefore, these parameters could not be used in evaluation of the vascular system and establishment of the cardiovascular prognosis by themselves. We found significant correlation between diabetes duration and arterial stiffness parameters which might demonstrate that arterial stiffness raises in parallel with the duration of diabetes. This finding could resolve the conflict between the results in the literature, mentioned above.
Hyperkinesis in the systemic and microvascular circulation
In our study, the heart rate was significantly higher in both diabetic groups compared to controls. Time to maximum flow during PORH test tended to be shorter in DMW patients. Skrha et al. found the same pattern in case of TM-PORH without significances, as well [19] . In contrary,
Gomes and colleges found a longer TM-PORH among diabetic patients [11] . None of these studies used the TM parameters by themselves, but for the calculation of velocity or area under curve. Meyer et al. found a delay of the PORH in diabetic patients. They explained the result as an effect of the redistribution of total skin microcirculation, caused by the insulin-induced increase in the capillary blood flow [27] . The shortening of the time parameters and the elevated heart rate might indicate diffuse hyperkinesis in the whole circulation system, which can be caused by the effect of insulin or can be the manifestation of the hyperkinetic stage of the disease [2] . In summary, we found decreased arterial stiffness and hyperkinesis in the systemic and microvascular circulation in patients with diabetes mellitus without complications. Several mechanisms might explain our results. We assume the common factor can be the hyperkinetic effect of insulin, although this hypothesis needs further investigation. Though both diabetic groups used insulin, in diabetic patients with microvascular complications the hyperkinetic effect of insulin may not occur because of the damage of the capilla-ries. Another possibility is that our findings represent the early, dilative stage of type 1 diabetes mellitus, reported previously [2] .
PERSPECTIvES
We demonstrated the impairment of the microcirculation in type 1 diabetic patients, even in the early, uncomplicated phase of the disease. We found impairment in the mi- 
